News | SCAI | May 07, 2024

Women and Black Patients Less Likely to Receive Catheter-based Treatment for Pulmonary Embolism According to REAL-PE Analysis Presented at SCAI 2024

Women and black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients, according to new data from the REAL-PE analysis which investigated catheter-based pulmonary embolism (PE) treatment. Late-breaking results from the study, for which Sahil A. Parikh, MD, Columbia University Irving Medical Center was lead author, were shared during the recently-held Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions. 

Women and black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients, according to new data from the REAL-PE analysis which investigated catheter-based pulmonary embolism (PE) treatment. Late-breaking results were presented by lead study author Sahil A. Parikh, MD, Director of Endovascular Services and Professor at Columbia University Irving Medical Center, at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.

Women and black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients, according to new data from the REAL-PE analysis which investigated catheter-based pulmonary embolism (PE) treatment. Late-breaking results were presented by lead study author Sahil A. Parikh, MD, Director of Endovascular Services and Professor at Columbia University Irving Medical Center, at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions, held May 2-4 in Long Beach, CA. 


May 7, 2024 — Women and black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients, according to new data from the REAL-PE analysis which investigated catheter-based pulmonary embolism (PE) treatment. The late-breaking results were presented in a session, “Disparities in Pulmonary Embolism Care: Insights from Big Data Analytics” during the recently-held Society for Cardiovascular Angiography & Interventions SCAI 2024 Scientific Sessions. A snapshot summary of the outcomes, as presented in a written statement issued by SCAI, follows.

Study Summary

REAL-PE analyzed data from patients within the Truveta database diagnosed with PE and treated with USCDT or MT for PE. Patient characteristics including race, ethnicity, age, sex, comorbidities, and prior diagnoses were assessed to investigate their association with the type of treatment used. Of the more than 430,000 patients diagnosed with PE, about 2,000 patients analyzed were treated with one of the invasive therapies. Women or black patients were less frequently treated with invasive therapy than men or non-Black patients. Moreover, women more than men and white people more than black people had higher bleeding rates.

Lead Author Sahil A. Parikh, MD Analysis

“Although this data demonstrates the value of real-world data in the assessments of new technologies in which randomized data are not always available, there is still work that needs to be done to evaluate the current utilization of advanced therapies for PE in underrepresented patient populations,” said Sahil A. Parikh, MD, Associate Professor of Medicine and Director of Endovascular Services, Columbia University Irving Medical Center, who was lead author of the study. “Evaluating care disparities in real clinical practices is key to addressing the existing barrier and improving patient outcomes,” Parikh added.

About Pulmonary Embolism

PE is often caused by blood clots in the legs, otherwise known as deep vein thrombosis, that travel through the veins and into the lungs. PE affects around 900,000 people in the U.S. each year, with 10-30% dying within one month of diagnosis. Ultrasound-assisted catheter-directed thrombolysis (USCDT), a common invasive treatment option for PE, enables deeper penetration of the clot-busting medication into the clot, restoring normal blood flow faster. Mechanical thrombectomy (MT), another invasive treatment method has been shown to reduce thrombus burden and pulmonary artery pressure (PAP) and to improve right ventricular (RV) function in patients with high-risk or intermediate-high-risk PE.

The Society for Cardiovascular Angiography & Interventions (SCAI) which was established in 1978, represents itself as the primary nonprofit medical society dedicated to representing invasive and interventional cardiology. Based in Washington, DC, SCAI's mission is to guide the global interventional cardiovascular community by fostering education, advocacy, research, and upholding standards for quality patient care among 4,500 members committed to advancing medical science and providing life-saving care for individuals of all ages affected by cardiovascular disease. Its SCAI Scientific Sessions 2024 were held May 2-4 in Long Beach, CA.

More information: www.scai.org

Find more SCAI 2024 news coverage from DAIC here.


Related Content

News | Cardiovascular Education

May 31, 2024 — In the United States there are over 8 million active athletes. Given the rapid expansion of sports ...

Home May 31, 2024
Home
News | Cardiovascular Education

April 25, 2024 —Heart-Valve-Surgery.com, a leading patient advocacy group for heart valve disease, with support from ...

Home April 25, 2024
Home
News | Cardiovascular Education

March 21, 2024 — The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of ...

Home March 21, 2024
Home
Feature | Cardiovascular Education | Christine Book

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country ...

Home February 01, 2024
Home
News | Cardiovascular Education

January 15, 2024 — A public-private partnership Think Tank, scheduled for Feb. 29-March 1, will be presented by the ...

Home January 15, 2024
Home
News | Cardiovascular Education

December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

Home December 04, 2023
Home
News | Cardiovascular Education

October 5, 2023 — The 2023 American College of Cardiology (ACC) Quality Summit kicks off on October 11-13 in Orlando ...

Home October 05, 2023
Home
News | Cardiovascular Education

DAIC’s award-winning editorial team delivers industry trends and technology information to the professionals who make ...

Home August 16, 2023
Home
Feature | Cardiovascular Education | Christine Book

May 4, 2023 — A new book on a broad collection of cases, led by a team of investigators from the Smidt Heart Institute ...

Home May 04, 2023
Home
News | Cardiovascular Education

April 10, 2023 — Viatris Inc., a global healthcare company, and the American College of Cardiology (ACC) today released ...

Home April 10, 2023
Home
Subscribe Now